BMO Capital Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform, 'Current Valuation Skews Risk/Reward to Upside'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 54.80 -0.09 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.89 | 52 Week High | $108.96 | |||
| Open | $54.80 | 52 Week Low | $62.12 | |||
| Day High | $55.98 | P/E | N/A | |||
| Day Low | $54.48 | EPS | $-1.27 | |||
| Volume | 2,146,365 | |||||
